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ABSTRACT 
This study investigated (1) the ability of an organotypic model of spinal cord injury (SCI) 
to recapitulate significant pathobiological events of in vivo SCI from a Raman 
spectroscopic perspective, and (2) the Raman spectroscopic effects of chondroitinase 
ABC (cABC) treatment on said model of SCI. Tissue from mouse spinal cords was 
excised, sectioned, and placed into culture, before being systematically injured to 
induce trauma. Cultures with and without cABC treatment were assessed using Raman 
spectroscopy at varying times post-injury. We demonstrate that Raman spectral 
phenomena characteristic of SCI can be observed using an organotypic model. By 
comparing these phenomena with well-known cellular mechanisms of SCI, we 
hypothesize their correlation with apoptosis, demyelination, and upregulation of 
endogenous biochemicals, such as chondroitin sulfate proteoglycans (CSPGs), among 
others. Furthermore, we demonstrate for the first time that Raman spectral phenomena 
are discernable during cABC treatment of SCI. Observed spectral variations correlate to 
the enzymatic degradation of CSPGs, protein compositional changes, and remyelination. 
Multivariate regression modeling confirms changes in lipid and chondroitin sulfate 
concentration during SCI and its cABC treatment, and provides a semi-quantitative 
measure of these changes. Overall, these data establish Raman spectroscopy as a 
viable resource for monitoring cABC treatment of SCI. 
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1     SPECIFIC AIMS 
1. Using Raman spectroscopy, assess the ability of an organotypic model of spinal 
cord injury (SCI) to recapitulate significant pathobiological events of in vivo SCI  
2. Using Raman spectroscopy, assess the effects of chondroitinase ABC (cABC) 
treatment on organotypic SCI, and whether those effects, if any, correlate to the 
reported enzymatic action of cABC on spinal tissue 
3. Construct a multivariate regression model of organotypic SCI and its treatment 
with cABC, using the acquired Raman spectra, to quantify changes in 
biochemical composition  
2     INTRODUCTION  
When the spinal cord is injured, it responds by producing an axonal inhibitory matrix 
referred to as the glial scar.1-3 This response prevents severed axons from forming new 
connections across the injury site, an event that, if done incorrectly, could be 
devastating to functionality in the central nervous system (CNS).1-3 Rather than risk a 
potentially detrimental reconnection, the injured spinal cord uses the scar to impede 
axonal regrowth and preserve its residual physical and chemical integrity. However, this 
preventative measure comes at a price, as many victims of spinal cord injury (SCI) 
consequently suffer partial or complete paralysis from failed axonal regeneration. SCI 
victims in the United States alone number approximately 270,000, and of those more 
than 99% are paralytic.4 To combat SCI and its debilitating effects, numerous efforts 
have been made to understand the underlying mechanisms of the glial scar.5-8 It is, at 
least in part, a function of two key events. First, axons extending into the site of injury 
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are demyelinated by the apoptosis of oligodendrocytes, the myelinating cells of the CNS. 
The apoptotic fragmentation of the oligodendrocyte membrane releases myelin-
associated growth inhibitors, which, when bound to complementary receptors, prohibit 
axonal growth. Additionally, demyelination prevents the proper electrical conductivity 
necessary for neurons to signal, making communication across the injury site highly 
improbable.8,9 Second, reactive glial cells concurrently, and vigorously, upregulate 
chondroitin sulfate proteoglycans (CSPGs), which are secreted to produce a CSPG-rich 
extracellular matrix. The chondroitin sulfate glycosaminoglycan (CS-GAG) side-chains 
of CSPGs then bind to complementary receptors on axons, triggering a signaling 
pathway to further prohibit axonal growth.9,10 Thus, CSPGs act as a physical barrier, by 
means of sheer concentration, and chemical barrier to axon regeneration.  
It is reported that CSPGs are among the most proactive of axonal inhibitory 
molecules.10 For this reason, numerous studies have focused on anti-CSPG SCI 
therapies using the bacterial enzyme chondroitinase ABC (cABC).1, 11-14 This enzyme 
catalyzes the removal of CS-GAG chains from CSPG, which in turn attenuates CSPG’s 
inhibitory action, both as a physical and chemical barrier. However, despite the success 
of anti-CSPG therapies, assessment thus far has relied on immunohistochemical 
techniques, which require preparation of tissue and further, possibly unwanted, 
alteration of the tissue’s chemical state (e.g. fixation and staining). In recent years, 
Raman spectroscopy (RS) has emerged as an effective alternative in examining tissue 
chemistry, one that is operable in living tissue without any necessary chemical 
treatments.15 Without the requirement of tissue preparation, RS has appreciable 
potential as a clinical tool for real-time assessment of SCI treatment. Ideally, the 
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spectroscopic technique would be used to non-invasively monitor the chemistry of 
treated SCI, facilitating necessary tailoring of the treatment. This study serves as a 
preliminary, in vitro exploratory effort to the aforementioned clinical therapy. The 
effectiveness of RS has already been demonstrated in the assessment of SCI.16,17 
However, no reports to date have used RS to examine the effects of anti-CSPG 
treatments. To that end, we present a novel Raman spectroscopic investigation, in 
qualitative and semi-quantitative nature, of SCI and its treatment with chondroitinase 
ABC in an organotypic model.  
Firstly, we demonstrate a functional model of SCI - on which our spectroscopic 
investigation was based - using an organotypic culture platform. The animal chosen for 
this model was the mouse. Organotypic cultures are tissue explants, typically in the 
form of thin slices, which have been placed directly into culture without modification. 
This style of preparation preserves the original histological and morphological structures 
of the tissue, allowing regional specific observations. Once in culture, organotypic slices 
largely maintain the ability to recapitulate in vivo pathobiology, despite lacking extrinsic 
inputs.18 This has been extensively demonstrated for tissue of the CNS.19-22 The 
organotypic culture platform was chosen, foremost, because it allows SCI to be 
performed entirely in vitro, facilitating a repeatability of injury that is amply more difficult 
to achieve in vivo.18 In this study, tissue was excised from the spinal cords of mice, 
sectioned into uniform slices, placed into culture, and systematically injured using a 
weight-drop device. In this way, the mechanics of injury were precisely controlled so 
that the injury mode and injury severity remained uniform between groups of tissue. 
Whereas the mechanics of in vivo injury can be controlled, it can only be done so 
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externally, meaning internal tissue injury cannot be regulated with the same degree of 
precision as in vitro injury.18 For our purposes uniformity of injury was necessary, as our 
assessment did not pertain to the level of injury severity. Moreover, in vitro injury is 
ethically advantageous to in vivo injury, as it does not necessitate post-surgical animal 
care. As an additional motive, organotypic cultures offer precise control over the 
environmental conditions of excised tissue, which allows highly repeatable treatment. 
Direct administration of cABC into the culture medium lessened the possibility of a non-
uniform drug distribution, to which a vascularized in vivo environment might be 
conducive, thus further removing variation between groups. Secondary motives include 
the cost effectiveness of the platform, since there is no post-surgical care, and ease-of-
use, since surgery was not required immediately prior to analysis, as is necessary in in 
vivo studies to prevent tissue decay.16  
With the SCI model in place, cultures with and without cABC treatment were 
assessed using Raman spectroscopy at varying times post-injury. We investigated (1) 
the ability of an organotypic model of SCI to recapitulate significant pathobiological 
events of in vivo SCI from a spectroscopic perspective and (2) the Raman 
spectroscopic effects of cABC on our model of SCI, and whether those effects 
correlated to the reported enzymatic action of cABC on spinal tissue. These 
characterizations are qualitative in nature. To quantitatively supplement our 
spectroscopic findings, partial least squares (PLS) regression was employed to 
construct a multivariate model of tissue composition during SCI and its treatment. The 
goal of the PLS regression was to ascertain the relative contribution of predetermined 
reference biochemicals, intrinsic to spinal tissue, to the chemical compositional profile of 
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organotypic spinal tissue cultures.  This was executed by finding the commonality 
between the spectra of the reference biochemicals and the spectra of the tissue.   
3    MATERIALS AND METHODS 
3.1 Preparation of organotypic spinal cord slice cultures   
The animal protocol was approved by the Institutional Animal Care and Use Committee 
(IACUC) at Syracuse University and was in compliance with the National Institutes of 
Health (NIH) guidelines. All following procedures were performed in a sterile laminar 
flow cabinet. Adult female mice (Mus musculus) were anesthetized with isoflurane and 
decapitated using a rodent and small animal guillotine. The animal was positioned 
ventral side up and pinned into place on an ice-cold dissection board. The skin and 
musculature were removed from the ventral side along the midline. The ventral half of 
the ribcage was removed, and all organs were cleared from the thoracic cavity to 
expose the vertebral column. Once exposed, the vertebral column was constantly 
superfused with sterile, ice-cold artificial cerebral spinal fluid (ACSF) [124 mM NaCl, 3 
mM KCl, 1.25 mM KH2PO4, 4 mM MgSO4, 2 mM CaCl2, 26 mM NaHCO3, 10 mM D-
glucose, 2 mM ascorbic acid, and 75 µM adenosine (Sigma, St. Louis, MO); pH 7.2] to 
slow the inflammatory response. To access the spinal cord, an incision was made 
through the pedicle on either side of the first thoracic vertebra (T1) and extended down 
the length of the thoracic spine, separating the vertebral bodies from the lamina. The 
vertebral bodies were then lifted from the cord. Using microscopic assistance, the dorsal 
and ventral roots were transected.  
Next, the thoracic region of cord (T1-T13) was excised and placed into a petri 
dish containing sterile, ice-cold ACSF. The thoracic region was chosen for its uniform 
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cross-sectional area. The time between decapitation and submersion of the spinal cord 
in ACSF was minimized to within 10 minutes to ensure minimal inflammation. The cord 
was transferred to a separate petri dish containing 30°C low gelling temperature 
agarose (4% w/v in ASCF), which was immediately placed on ice to induce gelation. 
Once gelled, an agarose block containing the cord was cut from the bulk using a scalpel 
and fixed onto a metal disk with cyanoacrylate. The embedded cord was cut into 400-
µm-thick transverse slices [Fig. 1(a)] using a tissue chopper (McIlwain, ON, Canada) 
equipped with a Feather double-edge carbon steel blade (Ted Pella, Redding, CA). The 
slices were immediately transferred into sterile, ice-cold ACSF, where they were gently 
stripped of meninges and checked for structural quality. Any incomplete or damaged 
slices were discarded.  
Finally, slices were transferred onto Millicell culture plate inserts (PTFE 
membrane, 0.4 µm pore size; EMD Millipore, Billerica, MA) using a sterile wide-end 
pipette. The slices were plated three per insert, and arranged without contact between 
one another. The culture inserts were placed into a 6-well plate, with each well 
containing 1.0 mL of culture medium. Culture medium consisted of 50% minimum 
essential medium (MEM) with L-glutamine (Invitrogen, Carlsbad, CA), 25% normal 
horse serum (Invitrogen), 25% Hank’s balanced salt solution (HBSS) (Invitrogen), 20 
mM HEPES (Invitrogen), 6.5 g/L D-glucose (Sigma), 50 µg/mL penicillin (Invitrogen), 50 
U/ml streptomycin (Invitrogen) and was adjusted to a pH of 7.3. In this method of 
culturing, adapted from Stoppini et al23, tissue slices have two distinct interfaces from 
which they receive necessary resources, an air-to-tissue interface and a medium-to-
tissue interface. Slices were allowed to passively warm to room temperature before 
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being placed in incubation at 37°C and 5% CO2. The cultures were incubated for a 
maximum of 14 days in vitro (DIV), and the medium was changed every 3 days. 
3.2 In vitro SCI   
Slices were cultured for 6 DIV before inducing SCI to allow acclimation to the culture 
conditions. SCI was induced using a weight drop apparatus housed in a sterile laminar 
flow cabinet. This technique was adapted from Krassioukov et al.24 A headed stainless 
steel pin with a 2.0 mm diameter head and 0.5 g total weight was dropped from a height 
of 5.0 mm onto the center of the slice [Fig. 1(a)]. The cross-sectional area of the head 
was sufficient to cover the entire slice surface. Immediately following injury, slices were 
placed back into incubation at 37°C and 5% CO2. Control slices were removed from 
incubation for an equivalent time period and placed back into incubation without injury. 
Injured (SCI) groups and uninjured control (CTL) groups were analyzed at 1, 4, and 8 
day(s) post-injury (DPI) [Fig. 1(b)].  
3.3 Measurement of cell death   
Cell death was assessed using the nucleic acid stain, propidium iodide (PI) (Invitrogen, 
Carlsbad, CA). PI is only permeable through the damaged membranes of non-viable 
cells. Upon cellular entry, PI binds to nucleic acids, causing a significant increase in its 
fluorescence emission maximum and a forward shift in its excitation and emission peaks. 
PI was dissolved in serum free medium [75% MEM with L-glutamine (Invitrogen), 25% 
HBSS (Invitrogen), 20 mM HEPES (Invitrogen), 6.5 g/L D-glucose (Sigma, St. Louis, 
MO), 50 µg/mL penicillin (Invitrogen), 50 U/ml streptomycin (Invitrogen); pH 7.3] at 5 
µg/ml. Serum free medium was used to reduce the fluorescence noise generated by 
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esterase activity found in normal horse serum. Slices were removed from their current 
medium, gently rinsed in 1X phosphate buffered saline (PBS) to remove residual serum, 
and introduced to 1.0 mL PI solution.  
Slices were then placed back into incubation at 37°C and 5% CO2 for 1 hour to allow for 
permeation of PI. Fluorescence intensity was measured using a LSM 710 Confocal 
Microscope (Zeiss, Germany) controlled by ZEN 2010 B SPI1 software (Zeiss). PI was 
excited with a 543 nm Helium-Neon laser, and emissions were collected with a 605–670 
nm band pass filter.  A z-stack of 5 images separated by 10 µm intervals was collected 
in 3 non-overlapping locations for each slice using a 10X objective. The field of view, 
 
Fig. 1  (a) Overview of organotypic culture preparation and injury. Left image shows the transverse cutting plane used 
to section the spinal cord; middle, the slice-interface culture method adopted from Stoppini et al.; right, the weight-
drop apparatus used for injury. (b) Timeframe of experimental procedure. Cultures were allowed a period of 6 DIV 
before injury to ensure healing from the harvesting procedure, with injury occurring on the 6th day. One hour post-
injury, cultures were treated, or not, with cABC. Spectroscopic and histological analysis was performed at 7, 10, and 
14 DIV, which correspond to 1, 4, and 8 DPI.  
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gain, and pinhole size were standardized for all images.  The mean emission intensity, a 
built-in function of the ZEN software, was collected for each image. Slices were then 
killed by submersion in 4°C PI (0.5 mg/ml solution in 1X PBS) for 72 hours. Using an 
identical procedure, dead slices were re-imaged to obtain a mean emission intensity 
that represented 100% cell death. The percent cell death for each slice was expressed 
as its ‘alive’ mean emission intensity normalized by its ‘dead’ mean emission intensity. 
To assess cell death over the duration of the culture period, groups of cultured slices 
(n=3) were analyzed at 1, 3, 7, 10, and 14 DIV. To assess cell death in response to SCI, 
SCI groups (n=3) and CTL groups (n=3) were analyzed at 1, 4, and 8 DPI. The variable 
‘n’ refers to the number of slices.  
3.4 Chondroitinase ABC treatment   
Lyophilized chondroitinase ABC (cABC) (Seikagaku Corporation, Tokyo, Japan) was 
reconstituted in a 0.01% aqueous bovine serum albumin solution (Invitrogen, Carlsbad, 
CA). A buffer solution consisting of 10 U/ml reconstituted cABC, 50 mM Tris (Invitrogen), 
60 mM sodium acetate (Sigma, St. Louis, MO), and 0.02% bovine serum albumin was 
added to culture medium for a final cABC concentration of 0.2 U/ml. This solution is 
referred to as cABC medium. Injured slices were cleared of culture medium and 
administered 1.0 ml of cABC medium 1-hour post-SCI. The cABC medium was 
refreshed every three days following initial treatment. Note that the in vitro half-life of 
cABC is approximately 8 days.12 As a sham-control, separate groups of injured slices 
were administered culture medium supplemented with 2.0% 1X PBS. Groups treated 
with cABC (SCI +cABC) and sham-control groups treated with PBS (SCI +Sham) were 
analyzed at 4 and 8 DPI.  
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3.5 Raman spectroscopy of organotypic cultures   
Raman spectroscopy was performed using a custom built Raman spectroscope 
(Fig. 2).25 For all procedures, an external cavity 785 nm laser diode (Process 
Instruments, Salt Lake City, Utah), adjusted to a measured power of 500 mW and spot 
size of 300 µm, was used as an excitation source. Excitation light was redirected 90° 
from the horizontal by a periscope and passed through a pinhole located in the center of 
a downward facing plane mirror. Excitation light then contacted the transverse plane of 
the tissue slice at normal incidence, and backscatter emissions were redirected back to 
the horizontal direction by the plane mirror. Emissions were passed through a pair of 
convex lenses and into a SuperNotch laser line rejection filter (Kaiser Optical Systems, 
Ann Arbor, MI) before entering a HoloSpec f/1.4 spectrograph (Kaiser) equipped with a 
100 µm entrance slit. The spectrograph had a low-frequency stokes grating that 
operated over the spectral range -34 to 1894 cm-1 and was coupled with a nitrogen-
cooled iDus 420 series CCD Detector (Andor, Belfast, UK) to produce a spectral 
resolution of 2.0 cm-1.  
Slices were cleared of culture medium and washed gently with PBS prior to 
imaging. Culture plate inserts containing the slices were removed from their 6-well 
plates and placed on an adjustable stage. Slices were positioned over an optical trap to 
reduce unwanted emissions. The laser focal spot was then positioned within the white 
matter of the spinal cord. Each spectrum was collected as 300 accumulations of 1.0-
second integrations (total time of 5 minutes), and a minimum of 3 spectra was collected 
per slice, with each spectrum taken from a unique location within the white matter. 
Between acquisitions, slices were superfused with room temperature PBS to maintain 
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hydration. Spectra of the PTFE membrane underlying the slices were collected under 
identical parameters. During spectroscopic analysis, PTFE spectra were subtracted 
from tissue spectra to remove the Raman spectral features contributed by the PTFE 
membrane (See Section 3.7). All experiments were done at room temperature. Slices 
were discarded following analysis. To assess how the culturing of spinal cord tissue 
affects its Raman spectral features, a group of uncultured slices (n=3) was analyzed 
immediately following slicing, and groups of cultured slices (n=3) were analyzed at 6, 
10, and 14 DIV. Uncultured slices underwent an identical preparation procedure to 
cultured slices, but were not placed in incubation and instead analyzed immediately 
following slicing. To asses the progression of SCI and its treatment with cABC, SCI 
groups (n=6) and CTL groups (n=3) were analyzed at 1, 4, and 8 DPI; and SCI +cABC 
groups (n=6) and SCI +Sham groups (n=3) were analyzed at 4 and 8 DPI.  The variable 
‘n’ refers to the number of slices. 
3.6 Raman spectroscopy of biochemical constituents   
See Section 3.5 for a description of the Raman spectroscope used to perform the 
following experiments. Triolein (≥99%), actin (from bovine muscle), cholesterol (≥99%), 
collagen type IV (from calf skin), collagen type I (from calf skin), chondroitin-6-sulfate 
(CS-C), chondroitin-4,6-sulfate (CS-E), glial fibrillary acidic protein (GFAP), myelin basic 
protein (≥90; bovine), histone (type IIA from calf thymus), and deoxyribonucleic acid 
(DNA) (from human placenta) (Sigma, St. Louis, MO) were chosen as representative 
biochemical constituents of spinal tissue, to be used for regression analysis. These 
chemicals were selected because they most likely represent the principal constituents 
that give rise to prominent Raman spectral features seen in spinal tissue.  
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Certain chemicals were chosen for their unique spectral characteristics, while others 
were chosen as general representations of their class of biomolecule. For example, 
triolein, a symmetrical triglyceride, was chosen as a representation of typical lipid 
vibrational modes, such as CH2 twisting and bending. All constituents, with the 
exception of triolein, which was purchased in solution, were purchased and analyzed as 
lyophilized powders. Powders were placed in a cylindrical quartz cuvette, and triolein 
was placed in a custom borosilicate glass tube with stopper. Each spectrum was 
collected as 1,200 accumulations of 1.0-second integrations (total time of 20 minutes), 
and a minimum of 3 spectra were collected for each constituent. Spectra from the 11 
biochemical species were used for regression analysis.  
 
	  
Fig. 2   Schematic of the custom-built Raman spectroscope used in this study. Red lines represent excitation light, 
while green lines represent emissions. The zoomed-in area shows the normal incidence of the excitation light to the 
transverse plane of the tissue slice. Note that the laser spot position was not fixed amongst tests, although the spot 
was always constrained to the white matter.  
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3.7 Spectroscopic data analysis   
Spectroscopic data sets were analyzed using MATLAB (Release 2011a; The 
Mathworks Inc., Natick, MA). Spectra were cropped to the finger print region of organic 
molecules (400 cm-1 to 1800 cm-1) and baseline corrected using the ‘msbackadj’ 
function in MATLAB. For each spectrum, the ‘msbackadj’ function estimated a baseline 
within multiple shifted windows (of 200 cm-1 width) and regressed the baseline using 
spline approximation before subtracting it from the spectrum. In this way, all Raman 
features narrower than 200 cm-1 are preserved, while those wider are considered a 
product of background fluorescence and therefore removed. Because the tissue slices 
were sufficiently thin, emissions from the underlying PTFE membrane were collected 
coincidently with tissue emissions, causing PTFE spectral features to appear within the 
tissue spectra. To correct for unwanted PTFE spectral features, an averaged PTFE 
membrane spectrum was subtracted from all tissue spectra. Subtraction was not 
performed on biochemical constituent spectra. Spectra were then smoothed using the 
‘mssgolay’ function in MATLAB, which applied a Savitzky-Golay smoothing filter. 
Standardization was performed by mean centering the data and dividing by the 
standard deviation, i.e. standard normal variable (SNV) transformation. For qualitative 
assessment, a numerical value was assigned to 10 peaks of interest present within the 
tissue spectra using the ‘findpeaks’ function in MATLAB.   
3.8 Modeling of spectroscopic data   
A semi-quantitative linear model of the spinal tissue spectra was rendered using partial 
least squares (PLS) regression. The PLS regression was performed in MATLAB 
(Release 2011a; The Mathworks Inc., Natick, MA) using a modified version of the 
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‘plsregress’ function. PLS regression was chosen for its ability to handle multicollinearity 
amongst predictor variables. The Raman spectra of biochemicals of a similar nature 
often share characteristic peaks, giving rise to a degree of correlation and hence 
necessitating the need for a regression technique capable of managing 
multicollinearity.26 Such was the case for the biochemical constituents chosen for this 
model (See Raman spectroscopy of biochemical constituents). The goal of the PLS 
regression model was to describe the commonality between the spectra of spinal tissue 
and the spectra of the 11 reference biochemical constituents. To this end, we extracted, 
from the regression, the relative contribution of each biochemical constituent spectrum 
to each spinal tissue spectrum. Then, using the relative contributions, we tracked 
fluctuations in each biochemical over the course of the in vitro SCI and cABC treatment 
timeframe. The basic form of the PLS regression model is given by: 
! = !" + !                                                                  (1) 
Where Y is an n-by-m response matrix, X is an n-by-p predictor matrix, β is a p-by-m 
matrix of linear coefficients, and R is an n-by-m matrix of response residuals.  For this 
study, Y corresponds to an n-by-m matrix composed of the tissue spectra for a 
particular group (e.g SCI at 1 DPI), where n is the number of spectral intensity 
observations and m is the number of spectra; X corresponds to an n-by-p matrix 
composed of the mean constituent spectra, where p is the number of constituents; and 
β corresponds to a p-by-m matrix composed of the relative contributions of each 
constituent. PLS regression is a multivariate technique that operates by projecting 
predictor and response variables (i.e. X and Y) to a new space.  X and Y are 
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simultaneously decomposed to find eigenvectors that explain a maximum amount of the 
covariance between X and Y. The projections of X and Y are given by: 
! = !!!!! + !!                                                            (2) 
! = !!!!! + !!                                                              (3) 
Where XS and YS are n-by-ncomp score matrices, with ncomp equal to the number of 
allowed PLS components. For this study, ncomp is equal to the total number of 
constituents so that ncomp equals p. The columns of XS and YS are the eigenvectors. X 
and Y are regressed onto Xs to find the predictor and response loading matrices, XL 
and YL respectively. XL is a p-by-ncomp matrix of predictor loadings, with row values 
corresponding to coefficients that estimate the original predictor variables; and YL is an 
m-by-ncomp matrix of response loadings, with row values corresponding to coefficients 
that estimate the original response variables. XR and YR are matrices that contain the 
residual from each projection. The linear coefficient matrix, β, can be given in terms of 
the response and predictor loading matrices as follows: 
! = !!!(!!!)!!                                                             (4) 
β provides linear coefficients that represent the relative contribution of each predictor 
variable, or constituent, on the response matrix. However, PLS regression may yield 
negative coefficients in β, which as contributions have no physical meaning. To 
eliminate negative values, the ‘plsregress’ function in MATLAB was modified to enforce 
a non-negativity constraint by replacing its original decomposition method of singular 
value decomposition (SVD) with non-nonnegative matrix factorization (NNMF). NNMF 
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was accomplished using the built-in ‘nnmf’ function. Rows in β were averaged to 
produce a mean linear coefficient for each constituent. Please recall that prior to 
regression, all spectra were SNV transformed to a mean of 0 and a standard deviation 
of 1; this produced standardized coefficients. For simplicity’s sake, the 7 constituents 
with the largest standardized linear coefficients, and thus the largest relative 
contribution to the tissue spectra, were selected for further analysis and discussion; they 
are triolein, actin, cholesterol, collagen type IV, CS-C, histone, and DNA. To assess the 
progression of SCI and its treatment with cABC, relative contributions were found using 
PLS regression for SCI groups (n=18) and CTL groups (n=9) at 1, 4, and 8 DPI; and for 
SCI+cABC groups (n=18) and SCI+Sham groups (n=9) at 4 and 8 DPI.  The variable ‘n’ 
refers to the number of measured spectra.   
3.9 Statistical analysis   
Statistical analysis was performed using MATLAB (Release 2011a; The Mathworks Inc., 
Natick, MA). Data are given as mean ± standard deviation (SD). All data, excluding that 
of SCI+cABC and SCI+Sham groups, were analyzed using one-way or two-way ANOVA 
as appropriate, followed by a post-hoc Tukey’s HSD test. Comparison between 
SCI+cABC and SCI+Sham groups was conducted using an unpaired Student’s t-test. 
For all tests, significance was assessed at p<0.05.  
4    RESULTS  
4.1 Viability of organotypic cultures   
Organotypic spinal cord slices were successfully cultured for up to 14 DIV using the 
interface method. Gross tissue morphology was visually inspected under microscopic 
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assistance once per day while in culture. We observed no discernable changes in the 
cross-sectional shape of the spinal cord over 14 DIV. Grey matter and white matter 
were easily distinguishable by visual examination, and both maintained their original 
shape and coloration. No degeneration or migration of the spinal horns or columns was 
seen. In most slices, a time-dependent flattening was observed, wherein tissue 
migrated outward from its original position, decreasing the height of the slice. Cell death 
significantly decreased following 1 DPI (p<0.05, Tukey’s HSD test) [Fig. 3(a)], which 
may indicate in vitro healing of the spinal tissue in response to excision and sectioning. 
There was no statistically significant difference between groups at 4, 7, 10, and 14 DIV, 
suggesting stability of cell death from 4 DIV to 14 DIV. The cell death averages for the 
aforementioned groups remained below a value of 12%. To ensure all cultures were 
stabilized prior to experimentation, a period of 6 DIV was allowed before the induction of 
SCI, as previously seen.27   
4.2 Cell death in response to SCI   
To induce SCI, a stainless steel weight was dropped from a fixed height onto the center 
of the spinal cord slice. Gross tissue morphology was visually inspected at 1, 4, and 8 
DPI. Starting at 4 DPI, we observed a slight curling of the slice edges away from the 
culture insert membrane, which indicates a loss of cell or extracellular matrix adhesion 
at the periphery. However, no changes in structure, location, or coloration of the white 
and grey matter were observed. A PI fluorescence assay was used to assess cell death 
at 1, 4, and 8 DPI. Compared to their controls, injured slices at each DPI time point 
demonstrated significantly increased cell death (p<0.05, Tukey’s HSD test): 1 DPI 
(12.3±4.1 vs. 7.9±1.9%), 4 DPI (26.7±5.9 vs. 7.7±2.1%), and 8 DPI (35.2±7.5 vs. 
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10.9±4.5%) [Fig. 3(b)]. Additionally, injured slices demonstrated a monotonic increase in 
cell death over time (p<0.05, Tukey’s HSD test) (12.3±4.1% @1 DPI, 26.7±5.9% @4 
DPI, 35.2±7.5% @8 DPI). Two-way ANOVA suggests there is a synergistic effect of 
time and injury on the severity of cell death (interaction p-value=5.18E-09). 
4.3 Raman Assignments 
 Raman spectra of spinal cord slice cultures were collected as previously described. 
Prominent Raman bands were labeled with a peak wavenumber value and assigned to 
a vibrational group/mode (Table 1). Vibrational groups were then assigned to a probable 
biochemical based on biological relevance to spinal tissue.  
 
Fig. 3  (a) Bar chart showing the percentage of cell death for uninjured spinal tissue cultures at varying DIV. Cell 
death decreases after 1 DIV and remains static at least until 14 DIV. Percentage of cell death was determined as 
described in Materials and Methods, and data are expressed as mean + SD.  Statistical significance was determined 
using one-way ANOVA followed by a post-hoc Tukey’s HSD test. Significance was assessed at p<0.05 and is 
denoted by an asterisk *. (b) Percentage of cell death for SCI groups at varying DPI. CTL groups are uninjured. All 
SCI groups show a significant increase in cell death relative to controls. Statistical significance was determined using 
two-way ANOVA followed by a post-hoc Tukey’s HSD test and was assessed at p<0.05. An asterisk denotes 
significance between SCI and CTL groups, while # denotes significance between SCI groups only. (c) Representative 
micrographs (10X) of PI staining. Scale bar=200 µm and is applicable to all micrographs. Noticeable increases in 
florescence are demonstrated for all groups.  
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Table 1  Band assignments for spinal tissue spectra. Greek letters denote the type of vibrational mode (υ=stretching, 
υs=symmetric stretching, δ=bending) and qualifiers denote the specific type of stretch/bend. Reference numbers refer 
to the assignment’s source. 
Peak Wavenumber 
(cm-1) Vibrational Group/Mode Biochemical Assignment 
Reference 
Number 
540 C-OH  Saccharides 28 
643 δ(C-C) twisting, C-S Tyrosine 29, 30, 31 
700 Sterol ring Cholesterol 17, 32 
890 C(1)-H β-anomers 28, 33, 34 
913 C-OH  Saccharides 28, 35 
1003 υs(C-C) breathing Phenyalanine 30, 33 
1064 υ(C-C) stretching Lipids 28, 31, 33 
1137 C-H, C-OH Saccharides 16 
1300 δ(CH2) twisting Lipids 31, 32, 35 
1445 δ(CH2) bending/scissoring Lipids 30-32 
1660 Amide I / υ(C=O) stretching Proteins / lipids 30-32 
 
4.4 Culturing has a negligible effect on the Raman spectra of organotypic spinal tissue 
To study the effect culturing has on the Raman features of spinal tissue, spectra were 
collected for cultured slices at 7, 10, and 14 DIV. As a control, spectra were collected 
from uncultured slices immediately following the excision and slicing procedure. Figure 
4A shows the mean, baseline-corrected, SNV transformed spectrum for each of the 
aforementioned groups. Spectra are stacked so that each spectrum is completely and 
easily discernable. In order to clearly see the variation between cultured and uncultured 
slices throughout the culture timeline, we provide difference spectra using the 
uncultured slice group as a reference [Fig. 4(b)]. Between-group comparison of peak 
intensity shows a statistically significant decrease at 700 cm-1 (sterol ring of cholesterol) 
between 7DIV/ 10 DIV and uncultured slices (p<0.05, Tukey’s HSD test) (Table 2). 
There are no statistical differences at any remaining peaks. These results indicate a  
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Fig. 4  (a) The mean, baseline-corrected, SNV-transformed spectra of uninjured, cultured spinal tissue at 6, 10, and 
14 DIV.  An uncultured spinal tissue spectrum is presented for comparison. Spectra are stacked to clearly show 
features. (b) Difference spectra obtained using the uncultured spectrum as a reference. The goal was to visualize the 
effect time in culture has on tissue spectra. Note that difference spectra were generated before stacking, using zero-
centered spectra.  
Table 2  Statistical comparison between peak intensities of uninjured groups at varying DIV, as determined by one-
way ANOVA followed by a post-hoc Tukey’s HSD test. Significant was assessed at p<0.05. Groups with dissimilar 
letters are significantly different. Dashes (-) denote no statistical significance between any groups.  
  Uninjured Groups 
Peak Wavenumber 
(cm-1) p-value Uncultured 6 DIV 10 DIV 14 DIV 
540 0.3243 - - - - 
700 0.0078 A B B A,B 
890 0.1213 - - - - 
913 0.0765 - - - - 
1003 0.0796 - - - - 
1064 0.4445 - - - - 
1137 0.1786 - - - - 
1300 0.0519 - - - - 
1445 0.4305 - - - - 
1660 0.3895 - - - - 
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possible drop in cholesterol concentration following initial incubation. Between 7 and 14 
DIV, however, we can infer there are no significant changes in the biochemistry 
contributing to Raman spectral features. These data, in conjunction with data on cell 
death, suggest a period of quiescence during the tissue’s second week in culture.   
4.5 Effect of SCI on the Raman spectra of organotypic spinal tissue  
To assess Raman spectral changes in response to SCI, spectra were collected for SCI 
groups at 1, 4, and 8 DPI. Spectra for uninjured CTL groups were collected at similar 
times. Figure 5(a) shows the mean, baseline-corrected, SNV transformed spectrum for 
SCI groups at 1,4, and 8 DPI. Statistical comparison between peak intensities was 
performed using one-way ANOVA with a post-hoc Tukey’s HSD test (p<0.05) (Table 3). 
For simplicity, only peaks of statistical significance are discussed. Note that a relative 
change in peak intensity is representative of a relative change in the concentration of a 
peak’s assigned biochemical. Monotonic decreases in intensity were seen at 1300 cm-1  
[δ(CH2) twisting of lipids] and 1445 cm-1  [δ(CH2) bending/scissoring of lipids]. These 
results suggest a time-dependent monotonic decrease in lipid concentration following 
SCI. Similar results have been observed using an in vivo model of SCI.16, 17 The peak at 
700 cm-1  (sterol ring of cholesterol) decreased between 1 DPI and 4 DPI, and is visually 
absent from the spectrum at 8 DIV. Other notable decreases occurred at 1064 cm-1 
([υ(C-C) stretching of lipids] and 1660 cm-1 [Amide I of proteins, υ(C=O) stretching of 
lipids] between 4 DPI and 8 DPI.  Monotonic increases were observed at 540 cm-1 (C-
OH of saccharides) and 913 cm-1 (C-OH of saccharides), with an additional increase at 
1137 cm-1 (C-H, C-OH of saccharides) between 4 DPI and 8 DPI. Interestingly, all 
increasing peaks are attributed to the deformation of C-OH. To further illustrate the  
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Fig. 5  (a) The mean, baseline-corrected, SNV-transformed spectra of untreated, injured spinal tissue at 1, 4, and 8 
DPI. Spectra are stacked to clearly show features. (b) Difference spectra obtained using uninjured control groups* (at 
their respective DPI) as a reference. The goal was to visualize the progression of injury over time relative to the 
uninjured state. Note that difference spectra were generated before stacking, using zero-centered spectra. 
	  
Table 3  Statistical comparison between peak intensities of SCI groups at varying DPI, as determined by one-way 
ANOVA followed by a post-hoc Tukey’s HSD test. Significant was assessed at p<0.05. Groups with dissimilar 
letters are significantly different.  
  SCI Groups 
Peak Wavenumber 
(cm-1) p-value 1 DPI 4 DPI 8 DPI 
540 3.85E-08 A B C 
700 2.55E-19 A B B 
890 2.28E-04 A A,B B 
913 1.94E-17 A B C 
1003 1.69E-12 A A B 
1064 8.29E-07 A A B 
1137 6.41E-09 A B B 
1300 9.95E-14 A B C 
1445 2.06E-21 A B C 
1660 2.66E-05 A A B 
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aforementioned spectral changes, difference spectra between SCI groups (1, 4, and 8 
DPI) and their corresponding controls (Uninjured slices at 1, 4, and 8 DPI, respectively) 
are provided in Figure 5(b). The goal of the difference spectra is to visualize the 
progression of injury over time, relative to the uninjured tissue state. 
4.6 Effect of cABC treatment on the Raman spectra of injured organotypic spinal tissue 
Injured spinal cord slices were treated with cABC (0.2 U/ml) 1-hour post-injury and 
spectra were collected at 4 and 8 DPI. Figure 6 shows the mean, baseline-corrected, 
SNV transformed spectrum for cABC-treated groups (SCI+cABC) and sham-treated 
control groups (SCI+Sham) at 4 and 8 DPI. Statistical comparison between cABC and 
Sham-treated groups was performed using an unpaired Student’s t-test, and 
significance was assessed at p<0.05 (Table 4). Compared to their control, cABC-treated 
slices showed significantly decreased intensity at 540 cm-1 (C-OH of saccharides) 
(p=7.61E-05 for 4 DPI; p=3.05E-03 for 8 DPI) and at 1137 cm-1 (C-H, C-OH of 
saccharides) (p=1.06E-02 for 4 DPI; p=1.49E-02 for 8 DPI), and significantly increased 
intensity at 890 cm-1 [C(1)-H of β-anomers] (p=2.34E-02 for 4 DPI; p=2.39E-07 for 8 DPI) 
and at 643 cm-1 [δ(C-C) twisting of proteins] (p=2.56E-04 for 4 DPI; p= 4.43E-02 for 8 
DPI). The peak at 643 cm-1 is completely absent from the spectra of sham-treated 
slices, which suggests a sudden rise in a new vibrational mode, C-C twisting/C-S 
stretching, following cABC treatment. At 8 DPI only, cABC slices showed significantly 
increased intensity at 1064 cm-1  [υ(C-C) stretching of lipids] (p=3.83E-04). The intensity 
changes at 540 cm-1, 1064 cm-1, and 1137 cm-1 are antagonistic to those produced by 
SCI. Again to further illustrate the aforementioned spectral changes, difference spectra 
between cABC-treated groups and their sham-treated controls are provided in Figure 6. 
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Fig. 6  The mean, background corrected, SNV-transformed spectra of cABC-treated and sham-treated spinal tissue at 
(a) 4 DPI and (a) 8 DPI. Spectra are stacked to clearly show features. Note that difference spectra (cABC-Sham) were 
generated before stacking using zero-centered spectra.  
	  
Table 4  Statistical comparison between peak intensities of cABC groups and their sham controls at varying DPI, as 
determined by an unpaired Student’s t-test. For quick reference, asterisks indicate level of significance, *p<0.05, 
**p<0.01.  
 p-value 
Peak Wavenumber 
(cm-1) 
cABC vs. Sham 
4 DPI 
cABC vs. Sham 
8 DPI 
540 **7.61E-05 **3.05E-03 
643 **2.56E-04  *4.43E-02 
700   5.11E-01   3.70E-01 
890  *2.34E-02 **2.39E-07 
913   6.63E-01     2.75E-01 
1003   7.88E-01   9.29E-01 
1064   8.41E-02 **3.82E-04 
1137  *1.06E-02  *1.49E-02 
1300   8.86E-01   6.60E-01 
1445   5.37E-02   7.51E-01 
1660   3.42E-01   2.52E-01 
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4.7 Success of PLS regression model   
Table 5 shows the percentage of variance explained in Y (matrix of response variables, 
see Equation 1) by the PLS regression for each modeled group. Explained variance (η2) 
serves as an index of goodness of fit and is analogous to the coefficient of 
determination (R2), typically used in multiple regression models. Values for η2 range 
from 63.66 to 84.68%. We can see from the response residual, taken as the difference 
between the fitted response and the average measured tissue spectrum, that a large 
portion of unexplained variance comes from the 540 cm-1 band and 1064 cm-1 band (Fig. 
7). This is especially true of SCI groups assessed later in culture, e.g. 8 DPI, as these 
bands increase significantly over the course of injury. However, despite the presence of 
weaker intensity bands in the fitted response, the PLS regression model is capable of 
largely resolving the response variance. Figure 8 shows the mean, baseline-corrected, 
SNV transformed spectrum for each of the 7 constituents chosen for discussion. These 
spectra were chosen for their higher standardized linear coefficient values, and offer the 
largest contribution amongst predictor variables to the PLS fitted response.  
4.8 Biochemical variations in response to SCI and cABC treatment   
PLS regression was used to ascertain the relative contribution of spectra from 11 
predetermined biochemical constituents to the spectra of cultured spinal tissue. As 
previously mentioned, the regression model output standardized linear coefficients for 
each constituent, which, for the purposes of discussion, will be referred to as a 
constituent’s relative contribution. Two models were constructed: the first for SCI groups 
and their uninjured controls, and the second for SCI+cABC groups and their  
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Table 5.  Percent variance explained by PLS regression for each modeled group  
Group Variance explained by model (%) 
Uninjured CTL (1 DPI) 83.39 
SCI (1 DPI) 84.68 
SCI (4 DPI) 75.53 
SCI +cABC (4 DPI) 80.48 
SCI +Sham (4 DPI) 77.35 
SCI (8 DPI) 63.66 
SCI +cABC (8 DPI) 71.87 
SCI +Sham (8 DPI) 69.61 
	  
	  
 
Fig. 7   Measured spinal tissue spectra versus the fitted responses generated by PLS regression. For simplicity control 
groups are not shown. Residual is the difference between measured and fitted.    
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sham-treated controls. Figure 9 depicts the relative contribution of the 7 constituents 
(chosen for discussion) for SCI groups at 1, 4, and 8 DPI. For simplification, a single 
CTL group was chosen for comparison. Since we observed no significant spectral 
differences between CTL groups at 1, 4, and 8 DPI (results not shown), the CTL group 
at 1 DPI was chosen arbitrarily to serve this purpose. Data are shown as mean ± SD, 
and between-group comparison was performed using a post-hoc Tukey’s HSD test 
(p<0.05). A notable increase in relative contribution was observed for CS-C following 1 
DPI; and notable decreases were observed for triolein, histone, and DNA following 1 
DPI, and for cholesterol following 4 DPI. Figure 10 depicts the relative contributions for 
cABC-treated and sham-treated groups at 4 DPI and 8 DPI. Here sham-treated groups 
are controls. Between-group comparison was performed using an unpaired Student’s t-
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Fig. 8  The mean, baseline-corrected, SNV-transformed spectra of the 7 biochemical species used for regression 
modeling. Spectra are stacked to clearly show features. 
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test, and significance was assessed at p<0.05. At 4 DPI, a significant increase in 
relative contribution, relative to the control, was observed for collagen type IV, while 
significant decreases were observed for cholesterol and CS-C. Similarly, at 8 DPI, a 
significant increase was observed for collagen type IV, while significant decreases were 
observed for cholesterol and CS-C.  
 
 
 
 
 
  
Fig. 9  Bar chart displaying the relative spectral contributions of biochemical species to injured spinal tissue at 1,4, and 8 
DPI. A single uninjured CTL group was chosen for comparison. Note that relative contribution values are unitless, as 
they are synonymous to standardized regression coefficients. Data are expressed as mean + SD. Statistical significance 
was determined using one-way ANOVA followed by a post-hoc Tukey’s HSD test. Significance was assessed at p<0.05 
and groups with dissimilar letters are significantly different. 
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5    DISCUSSION 
Raman spectroscopy is a powerful tool in examining compositional and conformational 
phenomena in living tissue. As mentioned, its success is demonstrated in the qualitative 
assessment of spinal cord tissue. However, no reports to date have used Raman 
spectroscopy to examine the effects of enzymatic treatment on SCI. This study presents 
a novel spectroscopic investigation, in qualitative and semi-quantitative nature, of SCI 
and its treatment with cABC in an organotypic model.  
Firstly, we generated a spectroscopic characterization of organotypic SCI using 
Raman spectroscopy. This allowed us to observe, from a spectroscopic perspective, 
which pathobiological events of SCI, if any, were functional in an organotypic setting. 
 
Fig. 10  Bar chart displaying the relative spectral contributions of biochemical species to cABC-treated and sham-
treated spinal tissue at (a) 4 DPI and (b) 8 DPI. Note that relative contribution values are unitless, as they are 
synonymous to standardized regression coefficients. Data are expressed as mean + SD. Statistical significance was 
determined using an unpaired Student’s t-test. Asterisks indicate levels of significance, * p<0.05, ** p<0.01.  
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We demonstrate that data in the present study exhibit strong agreement with previously 
established models of in vivo SCI16, 17; however, there are several developments that 
warrant discussion. Please note that the following discussion refers to significant 
differences between SCI groups and uninjured control groups, and that references for 
Raman assignments are listed in Table 1.  
Relative to uninjured tissue, we observed a monotonic decrease in peak intensity 
for bands at 1445 cm-1 and 1300 cm-1, over the timeframe of SCI. Both bands are 
attributed to CH2 bending in lipids, so accordingly their decrease in intensity likely 
correlates to a decrease in lipid concentration. This is because, under constant test 
conditions, spectral intensity (at a particular frequency) is assumed proportional to the 
concentration of whichever Raman-active chemical is vibrating at that frequency.16 
Since all tissue samples were maintained in vitro, a reduction in concentration implies 
either a degradation of the chemical, or its secretion from the tissue matrix. Reduction in 
lipid concentration is concurrent with demyelination, a hallmark feature of the glial scar, 
wherein axons are stripped of their myelin coating.8,9 Since myelin is largely composed 
of lipid molecules, a mass removal would likely reduce CH2 vibrational modes, and thus 
decrease correlated band intensities.  
Monotonic increases in peak intensity were observed at 540 cm-1 and 913 cm-1, 
both of which are attributed to C-OH deformation. For either band, the C-OH group is 
assigned to saccharides. Applicably, the 540 cm-1 band was observed in the spectra of 
aggrecan, a type of CSPG, and more specifically in the spectra of chondroitin sulfate-A 
and chondroitin sulfate-C, the unbranched polysaccharide side-chains of CSPGs.36 This 
report36 demonstrates an increase in intensity at 540 cm-1 during CSPG aggregation, a 
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well-documented event of the glial scar1,11-14,16, suggesting that our observation may be 
more specifically, and perhaps more appropriately, assigned to CSPGs. This additional 
assignment stands to reason, if only because CSPGs are a major Raman-active 
component of injured spinal tissue’s extracellular matrix16, and would therefore produce 
a significant spectral contribution. It should be noted that Raman spectroscopy is 
typically incapable of detecting chemicals of a concentration less than one part per 
thousand; so presumably, only chemicals of relatively high concentration within spinal 
tissue can produce observable spectral phenomena.  If the assignment were 
hypothesized correctly, the increase at 540 cm-1 would correlate to an upregulation of 
CSPGs, which is in agreement with SCI characteristics. The 913 cm-1 band has been 
observed in monosaccharides, such as glucose and ribose35; however, intriguingly is 
not found in the spectra of chondroitin sulfate, a chain of alternating monosaccharides 
that contains glucuronic acid, which is structurally similar to glucose. Nevertheless, the 
increase at 913 cm-1 suggests an increase in saccharide concentration following injury, 
which may also correlate to the upregulation of CSPGs.   
In all observed tissue spectra, the peak at 913 cm-1 overlaps with neighboring 
bands occupying the region from 800 cm-1 to 970 cm-1. Bands in this region are largely 
attributed to C-O-C deformation seen in the glycosidic linkages of oligo- and 
polysaccharides.37 We observed a monotonic increase in intensity over this entire 
region, which suggests the presence of newly formed glycosidic linkages. This is 
concurrent with CS-GAG polymerization during CSPG upregulation.  
Overall, these spectral phenomena are grossly concurrent with in vivo SCI, in 
that they suggest demyelination and CSPG upregulation, two major hallmarks of the 
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glial scar. Prior models of in vivo SCI demonstrate similar occurrences at 1445, 1300, 
and 700 cm-1 16,17; in the regions of 850-1000 cm-1 16,17; and below 600 cm-1 16. This last 
occurrence was not unanimous, but perhaps only because wavenumbers below 600 
cm-1 were left unobserved. Histological staining for myelin and immunohistochemical 
staining for chondroitin sulfate (types A and C) were used as references for spectral 
observations in the former study.16 Said staining revealed a decrease in myelin levels as 
early as 4 DPI, and an increase in chondroitin sulfate levels, also as early as 4 DPI. 
These results, while not conclusive in their correlation to spectral observations, serve as 
positive evidence for their spectral hypotheses, and by extension our spectral 
hypotheses, regarding CSPG and myelin variations.   
Secondly and subsequent to in vitro SCI, spinal tissue cultures were treated with 
cABC, a bacterial enzyme shown to attenuate the inhibitory properties of the glial scar. 
We demonstrate several key differences between the Raman spectra of cABC-treated 
spinal tissue and their sham-treated controls. This is significant for two reasons. First, it 
demonstrates that enzymatic treatment of SCI may be assessed spectroscopically. 
Second, it allows us to use the spectral differences to elucidate previously unknown 
mechanisms involved in the enzymatic reaction of cABC on injured spinal tissue. Unless 
stated otherwise, the following differences were observed between cABC-treated 
groups and sham-treated control groups at both collection times (4 and 8 DPI), and are 
statistically significant.   
The most notable difference, relative to the sham control, was a decrease in 
peak intensity at 540 cm-1. This change is antagonistic to the injury response and, 
based on our previous assignment for this band, would suggest a decrease in CSPG 
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concentration. Reduced CSPG concentration is in agreement with the characterized 
action of cABC since the enzyme degrades the CS-GAG chains of CSPG1, rendering its 
original chemical structure forfeit. Furthermore, this result fine-tunes the 540 cm-1 
chemical assignment from CSPG as a whole to, more specifically, its CS-GAG chains. 
This is because cABC only interacts with the saccharide chains of CSPGs and not the 
protein core38, so any spectral variations produced by cABC are firstly assumed a result 
of the enzyme-substrate interaction.  
We observed another notable decrease in peak intensity at 1137 cm-1. This band 
is attributed to C-H and C-OH deformation, and assigned to saccharides, suggesting a 
reduction in saccharide concentration post-treatment. If correctly assigned, this 
indicates depolymerized saccharides are eliminated from the extracellular matrix 
following the cABC enzymatic reaction. However, we cannot postulate a more direct 
correlation between the 1137 cm-1 band and cABC treatment, as the band has not been 
strongly observed in the spectrum of cABC or its substrate, chondroitin sulfate (see 
Figure 8 for CS-C spectrum).   
We observed an increase in peak intensity at 890 cm-1, which bears a specific 
assignment to β-anomers. β-anomers are cyclic saccharides that have a trans 
configuration between the OH group on C(1), also referred to as the anomeric carbon, 
and the CH2OH2 group on C(5). The exact vibrational group(s) that give rise to this band 
are debated; although the band appears to be resultant of a combination of vibrations 
found in β-anomers, including CH2, C-O(5), and C(1)-H deformations.35 Several studies 
affirm C(1)-H deformation as the primary contributor.28, 33, 34 Interestingly, CS-GAG 
chains are composed entirely of β-anomers, specifically glucuronic acid and 
 34 
galactosamine. These two monosaccharides are repeatedly linked together by 
glycosidic linkages between the C(1) of one monosaccharide and the C(4) of another to 
form chondroitin sulfate. Raman spectral analysis of chondroitin sulfate reveals a strong 
appearance of the band in the spectra of chondroitin-6-sulfate (CS-C) and a medium 
appearance in that of chondroitin-4-sulfate (CS-A).36 This data, along with details 
regarding the high extracellular concentrations of CSPGs during SCI39, suggests that 
our observation in spinal tissue may be more specifically assigned to chondroitin sulfate. 
Yet, while this information helps elucidate the source of spectral activity, it does not 
convey the reason for an increase in intensity. Any correlation between cABC treatment 
and increased β-anomer deformation is not apparent in the literature. However, we can 
speculate a cause. Studies have shown that cABC enzymatically degrades CS-GAG 
chains by cleaving the glycosidic linkages between its saccharide subunits40, which 
would directly affect the behavior of C(1), as it is an integral part of the linkage. Thus, 
cleavage of the linkage may increase deformation in C(1)-H, perhaps by alleviating 
vibrational hindrances caused by surrounding functional groups of the CS-GAG chain.    
A distinctive band at 643 cm-1 was observed in the spectra of cABC-treated 
tissue, but not in sham-treated controls. Vibrations at 643 cm-1 have two common 
assignments in the literature: the C-C twisting mode in tyrosine29,31, specifically within 
the phenol side-group, and the C-S stretching mode in sulfotyrosine.30 Because of the 
ambiguity in assignment for this band, we offer two possible explanations for its 
occurrence. First, if we assume the band is correctly assigned to C-S stretching in 
sulfotyrosine, its occurrence is likely an outcome of protein tyrosine sulfation, a post-
translational modification that is carried out on a variety of secreted and intra-membrane 
 35 
proteins.41 Protein tyrosine sulfation largely serves to strengthen, and thereby control, 
the interaction between secreted proteins and pathogens during the innate immune 
response.41 Treatment by the bacterial-derived cABC has been known to invoke an 
immune response10, and even in the extrinsically restricted environment of organotypic 
culture, spinal tissue is capable of producing an innate immune response without the 
influences of systemic cells because of the presence of microglia.42 If so, tyrosine 
sulfation would expectedly be a component of that response. Second, if the band is 
instead assigned to C-C stretching in tyrosine, its occurrence is likely due to 
conformational/compositional changes in protein structure. The spectral activity of the 
phenol side-group is highly sensitive to the orientation of its tyrosine residue29, so by 
affecting tyrosine orientation, it is feasible for a conformational/compositional change to 
increase intensity. This hypothesis is supplemented by a negative frequency shift from 
643 cm-1 to 640 cm-1, occurring between 4 and 8 DPI. The shift signifies a change in the 
stress/strain state of protein tyrosine, most likely caused by new vibrational groups 
surrounding protein tyrosine. Moreover, the shift signifies a continual 
conformational/compositional change to protein structure, one that evolves over the 
course of treatment. It is unclear exactly which proteins underwent changes, but we 
maintain CSPG core proteins as plausible candidates. 
Lastly, we observed an increase in peak intensity at 1064 cm-1 following 8 DPI. 
This band is attributed to C-C stretching in lipids. An increase in lipid concentration post-
treatment, however subtle, may indicate remyelination facilitated by the action of cABC, 
whether it be on previously demyelinated or newly sprouted axons. Under normal SCI 
conditions, CSPGs inhibit remyelination by physically and chemically restricting 
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endogenous oligodendrocyte progenitor cells (OPCs) from differentiating and 
consequently attaching to bare axons.8 During treatment, however, cABC overrides this 
inhibitory response on remyelination by enzymatically degrading CSPGs. With reduced 
CSPG action, OPCs are now free to myelinate. Intriguingly, this is the only significant 
difference that was not observed at both DPI. The lack of statistical difference between 
cABC-treated and sham-treated peaks at 1064 cm-1, and furthermore at 1300 cm-1 and 
1445 cm-1 (all assigned to lipids), following 4 DPI, suggests that cABC-treated tissue did, 
in fact, undergo demyelination. Therefore any subsequent increase in lipid 
concentration may correlate to remyelination.  
While comparing spectral intensities elucidates us to changes in concentration 
for biochemical species, it does so qualitatively and somewhat presumably, as it relies 
on tentative biochemical assignments. To help quantify the changes in biochemical 
species inherent in spinal tissue, we constructed two semi-quantitative linear models 
using PLS regression: one for SCI groups at varying DPI (1, 4, and 8 DPI), with 
uninjured controls, and another for cABC-treated groups at varying DPI (4 and 8 DPI), 
with sham-treated controls. For each biochemical constituent (chosen as a predictor 
variable), the PLS regression provides a standardized linear coefficient value that 
represents the constituent’s relative contribution to the spinal tissue spectrum (chosen 
as the response variable). Note that the following discussion refers to significant 
between-group changes in relative contribution. A change in contribution indicates that 
more/less of a biochemical is observed in the spectra of spinal tissue, which implies a 
change in the biochemical’s concentration. 
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From our regression model of SCI, we demonstrate that triolein and cholesterol 
monotonically decrease following injury. As previously stated, certain constituents were 
chosen for their unique spectral characteristics, while others were chosen as general 
representations of their class of biomolecule. Triolein and cholesterol were chosen as 
representation for typical lipid vibrational modes, such as CH2 twisting and bending, 
often present in the region from 1300 cm-1 to 1470 cm-1. A decrease in lipid contribution 
is concurrent with our spectral observations, and is indicative of demyelination. Histone 
and DNA were chosen as another such representation, albeit slightly different in nature. 
These constituents represent the characteristic vibrational modes contained within cell 
nuclei. We demonstrate a decrease in histone and DNA between 1 DPI and 4 DPI, with 
no further changes following 4 DPI. The results for histone are in agreement with other 
reports43,44, which demonstrate a release of histones from apoptotic cells during injury. 
From our results, we might further assume that histones are released from the 
extracellular matrix as well. Interestingly, the results for DNA are in disagreement with 
other reports that have spectroscopically characterized various pathologies.45, 46 When 
DNA undergoes denaturation - a regular occurrence in apoptotic cells and one well 
characterized in CNS injury18 - its secondary structure changes, which has a significant 
affect on its absorptivity.47, 48 Reports demonstrate that the absorptivity change 
associated with DNA denaturation produces Raman hyperchromic effects47, 48, so one 
would assume the contribution of DNA to increase, rather than decrease, in response to 
injury. However, these findings may prove irrelevant, as they were conducted with an 
excitation source ranging below 300 nm (compared to ours of 785 nm). We maintain 
that the Raman hyperchromic effect may not be detectable for larger wavelengths; or 
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rather may not be detectable amongst the assortment of spectral activity in spinal tissue. 
CS-C differed most notably out of the seven constituents, increasing by the largest 
factor between 1 and 8 DPI. An increase in chondroitin sulfate concentration during the 
first week of injury is well documented39, and our results are in agreement.  
From our regression model of cABC-treated SCI, we demonstrate a higher 
contribution from collagen type IV relative to sham-treated controls. Collagen type IV 
has not been previously characterized during cABC-treatment of SCI, so it is difficult to 
draw firm conclusions as to the cause of this result. However, one study reports that 
fibroblast-like cells present in the matrix of the annulus fibrosus, a component of the 
intervertebral disc, upregulate collagen in response to cABC treatment in an attempt to 
replenish the extracellular matrix of the disc.49 They observed a significant increase in 
collagen concentration as early as 7 days after cABC treatment. While the study is 
merely analogous to spinal tissue treatment, it is certainly helpful in elucidating a 
supposition. From their work, we adopt the hypothesis that collagen synthesis in spinal 
tissue is activated by chemical or mechanical changes to the extracellular matrix 
following CSPG degradation. Studies demonstrate that collagen has its own axonal 
inhibitory properties, and that the collagen-rich basal membrane found in spinal tissue 
acts as a barrier to axonal regrowth.6,9 So it is possible that cells upregulate collagen in 
an effort to restore or compensate for the inhibitory potential lost during cABC-treatment. 
This hypothesis implies that fibroblasts or fibroblast-like cells capable of synthesizing 
collagen, such as astrocytes, are present in the spinal tissue cultures. We demonstrate 
a lower contribution from cholesterol, relative to sham-controls, and no significant 
differences in triolein contribution. These data conflict with our initial spectra-derived 
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hypothesis of a decrease in lipid concentration following 8 DPI. This suggests one of 
two things. Either the 1064 cm-1 band, which is the band that prompted the initial 
hypothesis, is incorrectly assigned to lipids or perhaps shares a latent assignment to 
another, more relevant molecule; or the model’s explanation of variance within this 
spectral region is sufficiently low as to cause discrepancy between results. If the model 
were incapable of properly explaining variance in intensity at 1064 cm-1, then any 
changes in intensity, below a certain threshold, would be lost. A large residual around 
the 1064 cm-1 band, relative to all other bands (see Fig. 7), lends credibility to the latter 
supposition. Lastly, we demonstrate a sizeable decrease in CS-C relative to sham-
treated controls. At 8 DPI, CS-C contribution between cABC and sham-treated groups 
differs by the largest factor amongst constituents. A decrease in CS-C is in agreement 
with our spectral observations, as well as previous works1, 11-14, which demonstrate 
reduction in CS-GAGs concentration as early as 24 hours post-treatment.  
6    CONCLUSION 
In conclusion, we demonstrate that Raman spectral variations characteristic of SCI can 
be observed using an organotypic model. These variations are hypothesized to 
correlate with demyelination, CSPG upregulation, and apoptosis, among other events 
within injured spinal tissue. This is significant in that it indicates prominent 
pathobiological events associated with in vivo SCI can be recapitulated in vitro, as far as 
spectral analysis is concerned, so that we have a functioning model of SCI. Moreover, 
we have a model of SCI that can be systematically treated and assessed within a 
controlled environment. To that effect, we demonstrate for the first time that Raman 
spectral variations are discernable during cABC treatment of SCI. Observed variations 
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are hypothesized to correlate with the enzymatic degradation of CS-GAGs, protein 
conformational/ compositional changes, and remyelination. PLS regression modeling 
confirms changes in lipid (presumably that of myelin) and CSPG concentration during 
SCI and its cABC treatment, and provides a semi-quantitative measure of these 
changes. Overall, these data establish Raman spectroscopy as a viable resource for 
monitoring the treatment of SCI with the enzyme, cABC. As a result, it is intriguing to 
consider the implications of Raman spectroscopy in up-and-coming chondroitinase-
based SCI therapies.   
7    FUTURE WORK 
The PLS regression produced an average explained variance of 75.82%, leaving 
marked room for improvement. We conceive three primary reasons for the unexplained 
variance. First, the PLS model operates on the assumption that the Raman spectra of a 
biochemical in isolation is identical to its Raman spectra once its been incorporated in 
tissue. If this assumption is broken, and the incorporation of a biochemical causes shifts 
in frequency, the model’s ability to predict standardized coefficients could be adversely 
affected. Second, the set of predictor variables, i.e. biochemical constituents, chosen for 
this model may not have been optimal. If Raman bands found in the tissue are missing 
from the collection of reference spectra, the model will have a tendency to overfit certain 
predictor variables. This may have been the case for the 1064 cm-1 band. To correct 
this issue, one might consider using a semi-parametric model that accounts for the 
omission of relevant predictor variables using a non-parametric term. However, a 
challenge presents itself in creating a semi-parametric model with non-negative 
restrictions. Third, the non-negativity constraint on the regression may have increased 
 41 
unexplained variance, relative to unconstrained regression. Non-negative matrix 
factorization is not an exact factorization, but rather an approximation with a residual 
error component. Forcing non-negativity on the decomposition of predictor and 
response variables is necessary for analysis, but produces less than ideal results by 
introducing this error.  
Other improvements are needed in the analysis of spectroscopic data. Our 
analysis thus far has relied on the tentative assignment of Raman bands to 
biochemicals based on work from independent studies. While this practice is not an 
unusual tactic, it is highly presumptive and only aids in drawing hypothesis regarding 
spectral occurrences, rather than solid conclusions.  To better affirm these assignments, 
it is necessary to isolate and observe the chemical components of relevant 
pathobiological events. For example, one might assess the action of cABC on a solution 
of isolated CS or CSPG molecules. In situ spectral occurrences could then be 
compared to those of the cABC-CS/CSPG solution, so as to elucidate which 
occurrences were a direct result of the enzyme-substrate interaction and which were 
auxiliary. Additionally, a similar comparison could be performed using the spectra of 
activated glial cells in isolation of an extracellular matrix. This would help elucidate 
which spectral occurrences correlate specifically to cells versus the extracellular matrix, 
further identifying their source.  
One major disadvantage of the organotypic model is its lack of long-term viability. 
Reports show organotypic cultures of spinal cord tissue only maintain viability for an 
average of 2 weeks.20,22,50,51 Thus, to assess treatment over the full timeframe of SCI, 
the next major step for this work is in vivo experimentation. Ideally, injury and treatment 
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will be performed in a surgical setting, and the animal will be allowed a subsequent 
period of recovery. Herein lie two divergent paths that may be taken. Spectroscopic 
analysis will be performed either on excised sections of tissue, which requires 
euthanasia, or on the living animal as a whole. The latter is ideal, in that it mimics 
clinical applications, but it presents a wide-range of challenges, including imaging 
through bone and connective tissue, imaging in a vascularized environment, and 
anesthetizing the animal during imaging, to name a few. However, despite these 
challenges it is intriguing to consider RS for the clinical assessment of cABC SCI 
treatment. Furthermore, the generation of an in vivo model using a mouse would allow a 
more precise assessment the organotypic model’s ability to recapitulate major 
pathobiological events of SCI. While data in this study largely agreed with data of our 
previous in vivo model16, said model was constructed using an entirely different model 
organism, the rat. Cross-species comparison is useful in providing insight to the 
similarities between the models; however there is little way of inferring which differences 
correlate to the species and which to the models.  
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